CervoMed Inc (NASDAQ:CRVO) shares, rose in value, with the stock price up by 3.27% to the previous day’s close as strong demand from buyers drove the stock to $9.80.
Actively observing the price movement in the last trading, the stock closed the session at $9.49, falling within a range of $9.6 and $10.4. Referring to stock’s 52-week performance, its high was $25.69, and the low was $1.80. On the whole, CRVO has fluctuated by 4.59% over the past month.
With the market capitalization of CervoMed Inc currently standing at about $85.29 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-16.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 5.56M, with a low estimate of 1M and a high estimate of 3.01M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 1.7M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CRVO’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of CRVO currently trading nearly -0.61% and 60.18% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 55.40, while the 7-day volatility ratio is showing 14.98% which for the 30-day chart, stands at 24.91%. Furthermore, CervoMed Inc (CRVO)’s beta value is -0.24, and its average true range (ATR) is 1.79.
A comparison of CervoMed Inc (CRVO) with its peers suggests the former has fared considerably weaker in the market. CRVO showed an intraday change of 3.27% in last session, and over the past year, it shrunk by -60.56%%.
Data on historical trading for CervoMed Inc (NASDAQ:CRVO) indicates that the trading volumes over the past 10 days have averaged 0.61 and over the past 3 months, they’ve averaged 4.69 million. According to company’s latest data on outstanding shares, there are 8.70 million shares outstanding.
Nearly 35.20% of CervoMed Inc’s shares belong to company insiders and institutional investors own 17.09% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.11 million shares as on 2025-03-31, resulting in a short ratio of 0.09. According to the data, the short interest in CervoMed Inc (CRVO) stood at 1908.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 0.9 million. The stock has risen by 318.80% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CRVO stock heading into the next quarter.
